- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
915
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
915 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
LITI | SEK 8.22 | 3.0% | -5.5% | SEK 136.3m | n/a | PE1188.3x | E111.3% | n/a | Software | ||
WGX | AU$2.80 | -3.4% | 53.8% | AU$2.6b | AU$3.39 | PE27.7x | E36.5% | 0.9% | Materials | ||
600989 | CN¥14.40 | -2.2% | -0.5% | CN¥105.6b | CN¥21.69 | PE15.8x | E31.9% | 1.9% | Materials | ||
FLNC | US$21.09 | 8.5% | -17.1% | US$3.7b | US$27.37 | PS1.3x | E53.3% | n/a | Capital Goods | ||
KSPI | US$122.05 | -3.6% | n/a | US$23.2b | US$152.54 | PE11.9x | E22.5% | 5.8% | Diversified Financials | ||
FF | €8.06 | -2.9% | -4.0% | €197.3m | €12.25 | PB1.5x | E36.9% | 1.5% | Pharmaceuticals & Biotech | ||
2755 | CN¥10.93 | 0.09% | 38.4% | CN¥10.1b | CN¥13.00 | PE118.6x | E49.8% | 0% | Pharmaceuticals & Biotech | ||
SOFF | NOK 33.10 | -3.5% | 39.1% | NOK 3.1b | n/a | PB1.8x | E126.2% | 0% | Energy | ||
5218 | JP¥1,304.00 | -4.7% | -0.08% | JP¥31.2b | n/a | PE33.2x | E38.6% | 1.8% | Tech | ||
ALNSE | €29.30 | 1.0% | 19.1% | €93.0m | €27.80 | PE22.5x | E20.2% | 0.8% | Capital Goods | ||
MTAL | US$10.35 | 2.7% | -13.7% | US$767.0m | US$15.83 | PS2.4x | E85.2% | n/a | Materials | ||
MILDEF | SEK 81.70 | 0.7% | 6.1% | SEK 3.3b | SEK 90.50 | PE75.2x | E47.0% | 0.6% | Capital Goods | ||
TRIS3 | R$4.64 | -1.7% | -18.3% | R$843.2m | R$8.67 | PE6.6x | E20.4% | 1.5% | Consumer Durables | ||
6231 | NT$486.50 | -4.4% | 270.7% | NT$22.2b | NT$596.00 | PE78.6x | E56.4% | 0.4% | Software | ||
300048 | CN¥4.40 | 1.9% | -15.2% | CN¥4.8b | n/a | PS2x | E108.3% | 0% | Capital Goods | ||
ININ | NOK 3.26 | -3.6% | 3.2% | NOK 405.9m | NOK 4.90 | PB1.8x | E83.6% | n/a | Capital Goods | ||
SLEEP | SEK 40.40 | 0% | 70.5% | SEK 819.2m | SEK 55.00 | PE14.8x | E20.9% | 5.7% | Software | ||
603871 | CN¥17.99 | 2.8% | 46.9% | CN¥17.4b | CN¥23.33 | PE13.5x | E24.6% | 2.0% | Transportation | ||
7846 | JP¥4,495.00 | 4.3% | -10.4% | JP¥172.8b | JP¥5,400.00 | PE13.7x | E9.7% | 2.4% | Commercial Services | ||
300896 | CN¥137.89 | -1.9% | -55.5% | CN¥41.8b | CN¥264.39 | PE20.6x | E22.4% | 0% | Pharmaceuticals & Biotech | ||
2222 | JP¥1,738.50 | -2.7% | -25.3% | JP¥270.6b | JP¥2,453.33 | PE24.5x | E12.8% | 1.6% | Food, Beverage & Tobacco | ||
OC | US$159.90 | -0.05% | 16.9% | US$13.9b | US$186.68 | PE13.2x | E16.7% | 1.5% | Capital Goods | ||
DIA | €0.013 | -0.8% | -5.1% | €760.3m | n/a | PE-37x | E67.7% | 0% | Consumer Retailing | ||
PFIS | US$44.28 | -1.3% | 1.3% | US$441.7m | US$49.00 | PB1.3x | E103.3% | 5.6% | Banks |